Transforming The Management Of Critical Bleeding and Clotting
HemoSonics is bringing to market a next-generation point-of-care diagnostic platform, the Quantra™, that provides actionable information to guide the management of critical bleeding and clotting.
Our goal is to improve outcomes and reduce healthcare costs by enabling more targeted selection and dosing of blood products in critical settings. We seek to transform the way clinicians manage coagulation dysfunctions by providing comprehensive, timely and accurate information on coagulation status at the point of care, enabling clinicians to rapidly choose the right treatment, dramatically improving outcomes and lowering treatment costs.
Studies show that use of comprehensive point-of-care coagulation testing in surgical settings leads to:
Improved clinical outcomes
- Fewer transfusions
- Fewer complications
Reduced cost of care
- Reduced blood product utilization
- Shorter inpatient stays
HemoSonics Appoints Remi Corlin to Lead International Commercial Rollout of Quantra™ Hemostasis Analyzer System
Following CE Mark in April, HemoSonics Targets Distribution Partners at MEDICA 2017 Charlottesville, VA – October 19, 2017– HemoSonics today announced the appointment of Remi Corlin, a 20-year medical device and diagnostic industry veteran, as VP International Markets...read more
Charlottesville, VA – July 11, 2017– HemoSonics today announced the presentation of scientific and clinical data at the XXVI International Society on Thrombosis and Hemostasis (ISTH) Congress in Berlin, Germany. These abstracts demonstrate the excellent analytical...read more
The Stago group announced today that it has completed the acquisition of HemoSonics LLC, a company specialized in the development of innovative Point-of-Care testing solutions based in Charlottesville, VA, with facilities in Durham, NC (USA). With the acquisition of...read more
Charlottesville, VA - December 7, 2016 – The editorial staff of Anesthesia & Analgesia has chosen the article “A Novel Device for the Evaluation of Hemostatic Function in Critical Care Settings,” which details the Quantra™ Hemostasis Analyzer, as its Article of the...read more